Companion Animal Drugs Market Analysis

  • Report ID: 2964
  • Published Date: Nov 13, 2024
  • Report Format: PDF, PPT

Companion Animal Drugs Market Analysis

Product (Drugs (Antiparasitic, Anti-inflammatory), Vaccines, Medicated Feed Additives)

In terms of product type, drugs segment is likely to account for more than 55.1% companion animal drugs market share by the end of 2037. The demand for drugs is propelled by increasing attachment toward pets, establishing the focus on pet health. As the furry members have become a crucial part of the human family, owners are now willing to spend on high-quality drugs and treatments. They are taking preventive measures for chronic diseases by ensuring regular health check-ups and vaccinations. This has further pushed veterinary clinics to obtain health and nutrient-related drugs to offer on-spot medication. Drugs are being further developed to cure long-term or chronic diseases.

Animal Type (Dogs, Cats, Horses)

Based on animal type, the dog segment is predicted to capture a remarkable share of the companion animal drugs market during the forecast period. Dogs are one of the most desirable pets for their faithfulness and true affection. This has further inflated the adoption of dogs in a massive volume, increasing the demand for medication and additives related to these fur buddies. In a study conveyed by the NLM in September 2022, 91% of the total participants in the study expressed their desire to adopt a dog as their pet in the future. This acts as evidence of rising dog adoption from shelters and rescue centers, subsequently magnifying the need for specific medications.

Our in-depth analysis of the global market includes the following segments:

Product

  • Drugs
  • Antiparasitic
  • Anti-inflammatory
  • Anti-infectives
  • Corticosteroids
  • Tranquilizers
  • Cardiovascular Drugs
  • Gastrointestinal Drugs
  • Vaccines
  • Modified Live Vaccines (MLV)
  • Killed Inactivated Vaccines
  • Recombinant Vaccines
  • Medicated feed additives
  • Antibiotics
  • Vitamins
  • Amino acids
  • Enzymes
  • Antioxidants
  • Prebiotics and Probiotics
  • Minerals
  • Carbohydrates
  • Propandiol

Animal Type

  • Dogs
  • Cats
  • Horses
  • Other animals

Route of Administration

  • Oral
  • Injectable
  • Topical
  • Others

Distribution Channel

  • Veterinary hospital pharmacy
  • Retail pharmacy
  • E-commerce
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2964
  • Published Date: Nov 13, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the companion animal drugs market was over USD 21.3 billion.

The market size for the companion animal drugs market is projected to reach USD 51.8 billion by the end of 2037 expanding at a CAGR of 7.7% during the forecast period i.e., between 2025-2037.

The major players in the market are Agrolabo S.p.A., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Endovac Animal Health, HIPRA, Indian Immunologicals Ltd., Merck & Co., Inc., Norbrook, Symrise, Vetoquinol, Virbac, Zoetis Inc., and others.

In terms of products, the drugs segment is anticipated to garner the largest market share of 55.1% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 41.1% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample